Nexpoint Asset Management’s Portola Pharmaceuticals, Inc. PTLA Stock Holding History

Nexpoint Asset Management’s Portfolio PTLA Stock Details PTLA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q3	–	Sell	-132,607	Closed	-$2.39M	–	235
2020 Q2	$2.39M	Sell	132,607 -763,472	-85%	-$10.6M	0.54%	36
2020 Q1	$6.39M	Sell	896,079 -644,600	-42%	-$8.04M	1.21%	15
2019 Q4	$36.8M	Buy	1,540,679 +12,000	+0.8%	+$331K	2.79%	7
2019 Q3	$41M	Buy	+1,528,679	New	+$42.9M	2.56%	6

Nexpoint Asset Management's PTLA Position: Q3 2020 in Review

Nexpoint Asset Management sold out of Portola Pharmaceuticals, Inc. (PTLA) in Q3 2020, closing a stake of 132,607 shares — an estimated $2.39M sold.

Nexpoint Asset Management first reported a position in PTLA in Q3 2019 and held it in 4 quarters. The position peaked at $41M in Q3 2019. 0 funds tracked by Wall St. Rank hold PTLA as of Q3 2020.

Nexpoint Asset Management reported no remaining Portola Pharmaceuticals, Inc. position as of Q3 2020 after selling out during the quarter.
Nexpoint Asset Management sold 132,607 Portola Pharmaceuticals, Inc. shares in Q3 2020, an estimated $2.39M.
Nexpoint Asset Management first reported a position in Portola Pharmaceuticals, Inc. in Q3 2019 and held it in 4 quarters.
Nexpoint Asset Management's Portola Pharmaceuticals, Inc. position peaked at $41M in Q3 2019.
0 funds tracked by Wall St. Rank held Portola Pharmaceuticals, Inc. as of Q3 2020.

Based on Nexpoint Asset Management's 13F filing for Q3 2020, filed 16 Nov 2020.